Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:46 am Sale | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW INVESTMENTS LP | 2,637,192 6.000% | -391,527 (-12.93%) | Filing History |
| 2022-02-14 08:45 am Purchase | 2021-12-31 | 13G | Oyster Point Pharma, Inc. OYST | RTW INVESTMENTS LP | 2,058,504 7.900% | 132,910 (+6.90%) | Filing History |
| 2022-02-14 08:44 am Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW INVESTMENTS LP | 3,806,018 6.400% | -152,112 (-3.84%) | Filing History |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 2,186,324 7.900% | 673,651 (+44.53%) | Filing History |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | RTW INVESTMENTS LP | 2,520,076 6.500% | 423,233 (+20.18%) | Filing History |
| 2022-02-14 08:41 am Purchase | 2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW INVESTMENTS LP | 3,921,579 8.400% | 498,724 (+14.57%) | Filing History |
| 2022-02-14 08:41 am Sale | 2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | RTW INVESTMENTS LP | 2,353,015 6.700% | -409,776 (-14.83%) | Filing History |
| 2022-02-14 08:39 am Purchase | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | RTW INVESTMENTS LP | 2,980,960 6.600% | 2,980,960 (New Position) | Filing History |
| 2022-02-14 08:22 am Purchase | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 3,866,872 9.500% | 1,795,463 (+86.68%) | Filing History |
| 2022-02-14 08:21 am Purchase | 2021-12-31 | 13G | TELA Bio, Inc. TELA | RTW INVESTMENTS LP | 1,399,686 9.700% | 15,870 (+1.15%) | Filing History |
| 2022-02-14 08:20 am Unchanged | 2021-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW INVESTMENTS LP | 2,319,138 9.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:18 am Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 2,013,601 9.700% | -450,000 (-18.27%) | Filing History |
| 2022-02-14 08:16 am Purchase | 2021-12-31 | 13G | BrainsWay Ltd. BWAY | RTW INVESTMENTS LP | 3,204,762 9.700% | 997,814 (+45.21%) | Filing History |
| 2022-02-14 08:12 am Purchase | 2021-12-31 | 13G | Immunic, Inc. IMUX | RTW INVESTMENTS LP | 1,715,470 6.500% | 1,715,470 (New Position) | Filing History |
| 2022-02-14 08:12 am Purchase | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW INVESTMENTS LP | 5,810,140 9.990% | 422,627 (+7.84%) | Filing History |
| 2022-02-14 08:10 am Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW INVESTMENTS LP | 7,027,725 9.900% | 1,939,232 (+38.11%) | Filing History |
| 2022-02-14 08:09 am Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW INVESTMENTS LP | 1,906,557 5.100% | -779,222 (-29.01%) | Filing History |
| 2022-02-14 08:09 am Purchase | 2021-12-31 | 13G | Apyx Medical Corporation APYX | RTW INVESTMENTS LP | 3,398,279 9.900% | 7,000 (+0.21%) | Filing History |
| 2022-02-14 08:07 am Purchase | 2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW INVESTMENTS LP | 3,644,248 9.900% | 100,000 (+2.82%) | Filing History |
| 2022-02-14 08:07 am Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW INVESTMENTS LP | 2,599,822 5.400% | -1,050,247 (-28.77%) | Filing History |